Evidence map›Paper›PMID 30248247›Full record

ArticleJournal of diabetes investigation2019

Gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide signaling in adipose tissue.

Shunsuke Yamane, Norio Harada

Open access · goldAbstract readEditorial
In one paragraph

Article in Journal of diabetes investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shunsuke YamaneDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Norio HaradaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-8720-1013
Kyoto University · JP

Funding

Banyu Life Science Foundation InternationalJapan Association for Diabetes Education and CareJapan Diabetes FoundationJapan Society for the Promotion of ScienceMerck Sharp & Dohme (MSD)Ministry of Agriculture, Forestry and FisheriesMinistry of Education, Culture, Sports, Science and Technology (MEXT)Ministry of Health, Labor and WelfareNovo Nordisk Pharma
6 · The paper itself

Abstract

GIPR signaling in adipose tissue plays an important role in HFD-induced insulin resistance and hepatic steatosis in vivo, with no direct effect on fat accumulation, through IL-6 signaling.

Indexed as

Adipose TissueAnimalsDiabetes Mellitus, Type 2Gastric Inhibitory PolypeptideHumansInsulin ResistanceMice, KnockoutObesityReceptors, Gastrointestinal HormoneSignal TransductionGastric Inhibitory Polypeptidegastric inhibitory polypeptide receptorReceptors, Gastrointestinal Hormone

Identifiers

PMID30248247
PMCPMC6319611
OpenAlexW2892557185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.